Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Healthcare system

Premium increase in 2025 due to continued cost growth

  • Uncategorized
  • 2 minute read

The average health insurance premium will be CHF 378.70 per month in 2025, which corresponds to an increase of 6% compared to 2024. Premiums follow the costs. These will continue to grow in the future due to new therapies and medications as well as the ageing of society. Since this year, inflation has been increasingly reflected in tariffs, causing costs to rise noticeably. To ensure that the healthcare system remains financially viable, everyone is called upon to curb costs in the long term.

(red) In 2025, the average monthly premium will be CHF 378.70, which corresponds to an increase of CHF 21.60 compared to 2024. The average premium is calculated by adding up all premiums paid in Switzerland and dividing them by the total number of insured persons in Switzerland. The premiums are set by the insurers in such a way that the expected costs are covered for each insurer and each canton. The FOPH approved all submitted premiums for 2025 after a thorough examination of compliance with the legal provisions. Adjustments were requested where necessary.

The average premium increase of 6% is based on the insurers’ estimates of the changes in their portfolio of insured persons. However, the actual increase in premiums is expected to be lower, as more insured persons will choose higher deductibles or switch to an alternative insurance model if premiums rise more sharply, for example. As a result, the effective average premium level will fall. Taking these effects into account, as in previous years, the FOPH expects an effective increase of 5.5%.

Cost increases require increase

The rise in premiums is due to the growth in health insurance costs. With costs already growing faster than the long-term average at 4.6% in 2023, the increase in costs remains at a high level. The sharp rise in costs is due to a variety of factors, such as new medications and treatment options or the shift from inpatient treatment to outpatient care. In addition, insurers’ reserves have fallen to CHF 7.3 billion across the industry as at the beginning of 2024. The main reason for this is that healthcare costs grew more strongly in 2023 than expected at the time of premium submission.

Healthcare costs will continue to rise in the future due to the ageing population and new therapies and medicines. However, cost growth must be kept in check to ensure that the healthcare system remains financially viable in the long term. Cost containment is an ongoing task that must be tackled in various places by various players.

Source: www.bag.admin.ch/bag/de/home/das-bag/aktuell/news/news-26-09-2024-1.html (last accessed on 30.09.2024).

InFo NEUROLOGIE & PSYCHIATRIE 2024; 22(5): 40 (veröffentlicht am 21.10.24, ahead of print)
InFo ONKOLOGIE & HÄMATOLOGIE 2024; 12(5): 36

Publikation
  • InFo NEUROLOGIE & PSYCHIATRIE
  • InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
  • Health insurance
  • healthcare system
  • Premium increase
You May Also Like
View Post
  • 6 min
  • Respiratory infections: viral bronchitis or bacterial pneumonia?

Old crucial question in the light of current findings

    • Congress Reports
    • General Internal Medicine
    • Infectiology
    • Pharmaceutical medicine
    • Pharmacology and toxicology
    • Phytotherapy
    • Pneumology
    • RX
View Post
  • 6 min
  • What biomarkers reveal about "biological youth" - and what not (yet)

Epigenetic ageing

    • Education
    • Genetics
    • Geriatrics
    • Prevention and health care
    • RX
    • Studies
View Post
  • 4 min
  • Amyotrophic lateral sclerosis and nutrition

Calorie optimization in ALS through digital intervention

    • Education
    • Neurology
    • Nutrition
    • RX
    • Studies
View Post
  • 14 min
  • "Forgotten axis" between plant substances, gut and systemic health

Microbiome and phytotherapy

    • Education
    • Endocrinology and Diabetology
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Infectiology
    • Neurology
    • Nutrition
    • Pharmaceutical medicine
    • Phytotherapy
    • RX
    • Studies
View Post
  • 4 min
  • HIV: updated EACS guideline

Individualized approach to sustainable prevention and care

    • Cardiology
    • Education
    • General Internal Medicine
    • Infectiology
    • Prevention and health care
    • RX
    • Studies
View Post
  • 5 min
  • Evidence-based diagnostics and treatment in the medical setting

Anxiety and depression disorders in adolescence

    • Education
    • Pediatrics
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 25 min
  • Neuroenhancement

Can you swallow intelligence? Relevant substance classes times for healthy people

    • CME continuing education
    • Neurology
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 9 min
  • Microbiome, inflammaging and affective/cognitive health

Gut-brain axis in old age

    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Geriatrics
    • Neurology
    • Nutrition
    • Prevention and health care
    • RX
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Can you swallow intelligence? Relevant substance classes times for healthy people
  • 2
    Clinical care from birth to adulthood
  • 3
    Aligning care with the patient
  • 4
    Control instead of a flood of data: AI makes big data and wearables usable
  • 5
    Causes and prevention at work

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.